icon bookmark-bicon bookmarkicon cameraicon checkicon chevron downicon chevron lefticon chevron righticon chevron upicon closeicon v-compressicon downloadicon editicon v-expandicon fbicon fileicon filtericon flag ruicon full chevron downicon full chevron lefticon full chevron righticon full chevron upicon gpicon insicon mailicon moveicon-musicicon mutedicon nomutedicon okicon v-pauseicon v-playicon searchicon shareicon sign inicon sign upicon stepbackicon stepforicon swipe downicon tagicon tagsicon tgicon trashicon twicon vkicon yticon wticon fm

Pharmstandard 1H net profit up 51.5% year on year

Pharmstandard 1H net profit up 51.5% year on year
Russian drugmaker, Pharmstandard, has posted a 1H 2011 net profit of 4.189 billion roubles under IFRS.

The net result is up 51.5% year on year with 1H EBITDA up 42.3% year on year to 5.446 billion roubles, on the back of a 59.8% year on year increase in revenues to 18.450 billion roubles.

The company says the figures reflect a 17% year on year increase in over the counter sales to 6.641 billion roubles, coupled with a 3.2% year on year increase in prescription sales to 1.638 billion roubles.

Pharmstandard noted it had invested 731 million roubles into the development of manufacturing and warehousing capacities Including construction of new storage facilities and modernization of manufacturing facilities at OJSC Pharmstandard-Leksredstva and OJSC Pharmstandard-Ufavita, as well as commencing construction of cytostatic products production facilities at OJSC Pharmstandard-Ufavita.

Podcasts